Lifestyle and Energy Balance for Breast Cancer Survivorship
(MILES Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The MILES Study is a longitudinal, mixed-methods investigation of urinary biomarkers, energy balance, and lifestyle modifications in diverse women during early breast cancer treatment. The study's overarching goal is to assess dietary quality and physical activity changes over time using reliable, scalable tools suitable for clinical or population settings, supporting newly diagnosed patients in adopting and maintaining healthy behaviors through treatment and survivorship.
Are You a Good Fit for This Trial?
This trial is for adult women (18+) who have been newly diagnosed with stage 0-III breast cancer within the past 60 days and are scheduled for surgery at Penn Medicine. Participants must be able to read English or Spanish. Pregnant women and those without a new diagnosis cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Collection of lifestyle behavior data and urine samples at diagnosis
Post-Surgery Assessment
Collection of lifestyle behavior data and urine samples 1 month after surgery
6-Month Follow-up
Collection of lifestyle behavior data and urine samples 6 months after surgery
Follow-up
Participants are monitored for lifestyle behavior changes and metabolomics data correlation
What Are the Treatments Tested in This Trial?
Trial Overview
The study tracks lifestyle changes, diet, and physical activity in breast cancer patients using surveys, urine samples, and interviews over time to better understand how these factors affect recovery during treatment.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Among a sample of 100 women with newly diagnosed breast cancer, the study aims to collect novel lifestyle behavior data across three time points-at diagnosis, 1 month after surgery, and 6 months after surgery. Surveys will evaluate dietary quality, physical activity, tobacco use, demographic and socio-economic/occupation factors and perspectives about participation in biomedical/biospecimen research. The study will also collect the first urine of the day from these volunteers on the same day that they complete the lifestyle questionnaires. The urine will be used for metabolomics testing via Nuclear Magnetic Resonance (NMR) spectroscopy and will be correlated with the survey data.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Abramson Cancer Center at Penn Medicine
Lead Sponsor
Penn State University
Collaborator
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.